Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...

A Virginia House committee on Tuesday advanced a bipartisan proposal to create a Prescription Drug Affordability Board, ...

Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

Senior citizen enrolled in Medicare Part D prescription coverage will now have out-of-pocket drug costs capped at $2,000 a ...

What did consumers pay before this year's cap? Medicare, the federal health program for adults over 65 and the disabled, covers prescription drugs through Part D insurance plans. In past years ...